DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lithium Citrate (Lithium) - Humerus Fracture - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Humerus Fracture (37)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Lithium Citrate (Lithium) where reactions include humerus fracture. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 37   Next >>

Possible Lithium Citrate side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-06

Patient: female, weighing 103.0 kg (226.6 pounds)

Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Overdose, Myoglobin Blood Increased, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1+0+0+1.5 (6 millimoles)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 80 mg
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-07-05

Patient: 72 year old female

Reactions: Rhabdomyolysis, Post Procedural Complication, Lactic Acidosis, Constipation, Fall, Liver Disorder, Multi-Organ Failure, Dialysis, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Polydipsia, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Lacunar Infarction, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol;unk;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Curetter; Kalimklorid; Centyl MED



Possible Lithium Citrate side effects in female

Reported by a physician from Denmark on 2012-06-29

Patient: female

Reactions: Osteosynthesis, Humerus Fracture, Rhabdomyolysis, Dyspnoea, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Cardiac Hypertrophy, Hepatic Cirrhosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam



Possible Lithium Citrate side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-28

Patient: female

Reactions: Humerus Fracture, Osteosynthesis, Dyspnoea, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Cardiac Hypertrophy, Hepatic Cirrhosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol, unk
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone HCL
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Centyl MED Kaliumklorid; Fragmin; Ferro Duretter; Amlodipine Actavis; Alprazolam



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-26

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Lactic Acidosis, Fall, Organ Failure, Multi-Organ Failure, Hyperventilation, Renal Failure, Lacunar Infarction, Depressed Level of Consciousness, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Lithium Citrate
    Dosage: po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Other drugs received by patient: K CL TAB; Ferro Duretter; Alprazolam



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-22

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Confusional State, Osteosynthesis, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Centyl K; Ferro Duretter; Alprazolam



Possible Lithium Citrate side effects in female

Reported by a physician from Denmark on 2012-06-22

Patient: female

Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Dyspnoea, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cipralex
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Centyl MED Kaliumklorid; Alprazolam



Possible Lithium Citrate side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-22

Patient: female

Reactions: Confusional State, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Lacunar Infarction, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Escitalopram
    Dosage: 30 mg, qd
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1.5 df (in the evening)
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1 df (in the morning)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid
    Administration route: Oral
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Alprazolam; Centyl MED Kaliumklorid; Ferro Duretter



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-22

Patient: 72 year old female

Reactions: Confusional State, Rhabdomyolysis, Post Procedural Complication, Lactic Acidosis, Pyrexia, Serotonin Syndrome, Constipation, Fall, Hyperventilation, Multi-Organ Failure, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, General Physical Health Deterioration, Organ Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg, qd, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid, po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Duretter; Centyl MED; Kaliumklorid



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-19

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Rhabdomyolysis, Serotonin Syndrome, Lactic Acidosis, Constipation, Fall, Dialysis, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Lacunar Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Lithium Citrate
    Dosage: po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2005-01-01
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Alprazolam; K CL TAB



Possible Lithium Citrate side effects in female

Reported by a physician from Denmark on 2012-06-15

Patient: female

Reactions: Confusional State, Rhabdomyolysis, Pyrexia, Lactic Acidosis, Constipation, Fall, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1 df (in the morning)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1.5 df (in the evening)
    Administration route: Oral
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: styrke: 40 mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Duretter; Centyl MED Kaliumklorid



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-06-11

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Renal Failure, Depressed Level of Consciousness, Lacunar Infarction, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Fragmin; Ferro Duretter; Amlodipine; Centyl K; Furosemide



Possible Lithium Citrate side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-13

Patient: female

Reactions: Humerus Fracture, Dyspnoea, Rhabdomyolysis, Pyrexia, Lactic Acidosis, Constipation, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension, Myocardial Infarction, Cardiac Hypertrophy

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1 df (in the morning)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1.5 df (in the evening)
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Dosage: dosis: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: styrke: 40 mg
    Administration route: Oral
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Amlodipine; Fragmin; Centyl MED Kaliumklorid; Ferro Duretter; Furosemide



Possible Lithium Citrate side effects in 72 year old female

Reported by a pharmacist from Denmark on 2012-02-27

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Urinary Tract Infection, Lactic Acidosis, Serotonin Syndrome, Fall, Constipation, Cardiomegaly, Hyperventilation, Multi-Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Hypertension, Hepatic Cirrhosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg (30 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg (30 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 80 mg (40 mg, 2 in 1 d)
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Dureter (Ferrous Sulfate); Amlodipine; Furosemide; Fragmin (Dalteparin Sodiuim); Centyl MED Kaliumklorid (Bendroflumethazide, Potassium Chloride)



Possible Lithium Citrate side effects in 72 year old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-21

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Rhabdomyolysis, Lactic Acidosis, Serotonin Syndrome, Fall, Constipation, Cardiac Disorder, Liver Disorder, Multi-Organ Failure, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Cardiac Enzymes Increased, Urinary Tract Infection, Hepatic Enzyme Increased, Lacunar Infarction, Depressed Level of Consciousness, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg (30 mg, 1 in 1 d),oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg (30 mg, 1in 1 d),oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 80 mg (40 mg, 2 in 1 d)
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Amlodipine; Fragmin (Dalteparin Sodium)(dalteparin Sodium); Ferro Duretter(ferrous Sulfate)(ferrous Sulfate); Alprazolam; Centyl MED Kaliumklorid(bendroflumethazide, Potassium Chloride)(bendro; Furix (Furosemide) (Furosemide)



Possible Lithium Citrate side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-16

Patient: female

Reactions: Osteosynthesis, Humerus Fracture, Rhabdomyolysis, Dyspnoea, Pyrexia, Lactic Acidosis, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol, unk
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone HCL
    Dosage: 40 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Furosemide; Ferro Duretter; Amlodipine Actavis; Centyl MED Kaliumklorid; Fragmin; Alprazolam



Possible Lithium Citrate side effects in female

Reported by a physician from Denmark on 2012-02-13

Patient: female

Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Dyspnoea, Pyrexia, Lactic Acidosis, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Fragmin; Ferro Duretter; Furosemide; Alprazolam; Centyl MED Kaliumklorid; Amlodipin ^actavis^



Possible Lithium Citrate side effects in 72 year old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-13

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Osteosynthesis, Rhabdomyolysis, Lactic Acidosis, Constipation, Fall, Liver Disorder, Cardiac Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hepatic Enzyme Increased, Organ Failure, Depressed Level of Consciousness, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg (30 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 (30 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 80 (40 mg, 2 in 1 d),
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferro Duretter (Ferrous Gluconate); Furosemide; Amlodipine; Fragmin; Centyl MED Kaliumklorid (Bendroflumethazide, Potassium Chloride)



Possible Lithium Citrate side effects in 72 year old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-08

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Rhabdomyolysis, Pyrexia, Lactic Acidosis, Constipation, Fall, Hyperventilation, Neuroleptic Malignant Syndrome, Myocardial Infarction, Cardiac Hypertrophy, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Hepatic Enzyme Increased, Organ Failure, Depressed Level of Consciousness, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dosis: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: styrke: 30mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: styrke: 40 mg
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Ferrous Sulfate TAB; Centyl MED Kaliumklorid; Fragmin; Amlodipine; Furosemide



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-02-07

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Osteosynthesis, Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Constipation, Fall, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Organ Failure, Hepatic Enzyme Increased, Renal Failure, Lacunar Infarction, Depressed Level of Consciousness, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Amlodipine; Alprazolam; Furosemide; Centyl K; Fragmin; Ferro Duretter



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-02-07

Patient: 72 year old female

Reactions: Humerus Fracture, Osteosynthesis, Dyspnoea, Rhabdomyolysis, Lactic Acidosis, Pyrexia, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Hypertension

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Furosemide; Ferro Duretter; Alprazolam; Centyl MED; Kaliumklorid; Amlodipine; Fragmin



Possible Lithium Citrate side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-03

Patient: female

Reactions: Humerus Fracture, Rhabdomyolysis, Dyspnoea, Pyrexia, Lactic Acidosis, Constipation, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hypertension, Myocardial Infarction

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, qd (daily dose of 1 tablet in the morning and 1.5 tablet in the evening)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1 df (in the morning)
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1.5 df (in the evening)
    Administration route: Oral
    End date: 2011-10-23

Lithium Citrate
    Dosage: dosis: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: styrke: 40 mg
    Administration route: Oral
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Ferro Duretter; Furosemide; Amlodipine; Alprazolam; Fragmin; Centyl MED Kaliumklorid



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-02-01

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Osteosynthesis, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Lactic Acidosis, Pyrexia, Fall, Constipation, Liver Disorder, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Hyperdynamic Left Ventricle, Organ Failure, Hepatic Enzyme Increased, Renal Failure, Lacunar Infarction, Depressed Level of Consciousness, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Fragmin; Alprazolam; Amlodipine; Ferro Duretter; Centyl MED Kaliumklorid; Furosemide



Possible Lithium Citrate side effects in female

Reported by a physician from Denmark on 2012-01-30

Patient: female, weighing 103.0 kg (226.6 pounds)

Reactions: Rhabdomyolysis, Pyrexia, Lactic Acidosis, Fall, Constipation, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Depressed Level of Consciousness, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, qd
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, bid
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: K CL TAB; Ferro Duretter; Fragmin; Furosemide; Alprazolam; Amlodipine



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-01-20

Patient: 72 year old female, weighing 103.0 kg (226.6 pounds)

Reactions: Rhabdomyolysis, Lactic Acidosis, Serotonin Syndrome, Pyrexia, Constipation, Fall, Multi-Organ Failure, Hyperventilation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Myocardial Infarction, Hepatic Cirrhosis, Renal Failure Acute, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Cardiac Enzymes Increased, Hyperdynamic Left Ventricle, Depressed Level of Consciousness, Lacunar Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Furosemide; Alprazolam; Amlodipine; Fragmin; K CL TAB; Ferro Duretter



Possible Lithium Citrate side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-01-06

Patient: female

Reactions: Osteosynthesis, Humerus Fracture, Rhabdomyolysis, Dyspnoea, Pyrexia, Lactic Acidosis, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 6 mmol, unk
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone HCL
    Dosage: 40 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Amlodipine Actavis; Centyl MED Kaliumklorid; Furosemide; Fragmin; Ferro Duretter



Possible Lithium Citrate side effects in 72 year old female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-01-05

Patient: 72 year old female

Reactions: Humerus Fracture, Rhabdomyolysis, Cardiac Enzymes Increased, Lactic Acidosis, Fall, Hyperdynamic Left Ventricle, Organ Failure, Renal Failure, Lacunar Infarction, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hypertension, Myocardial Infarction, Hepatic Cirrhosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg (30 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: 1+0+0+1.5,oral
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg (30 mg,1 in 1 d),oral
    Administration route: Oral
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 80 mg (40 mg,2 in 1 d)
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Centyl MED Kaliumklorid (Bendroflumethazide, Potassium Chloride); Amlodipin ^actavis^ (Amlodipine Besilate); Alprazolam; Ferro Duretter (Ferrous Gluconate); Fragmin



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-01-04

Patient: 72 year old female

Reactions: Humerus Fracture, Rhabdomyolysis, Renal Failure, Lactic Acidosis, Neuroleptic Malignant Syndrome, Fall, Organ Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram Oxalate
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg;qd;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone HCL
    Dosage: 40 mg;bid;po
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Alprazolam; Amlodipine; Ferro Duretter; Fragmin; Furosemide; K CL TAB



Possible Lithium Citrate side effects in 72 year old female

Reported by a physician from Denmark on 2012-01-04

Patient: 72 year old female

Reactions: Osteosynthesis, Rhabdomyolysis, Pyrexia, Lactic Acidosis, Fall, Constipation, Neuroleptic Malignant Syndrome, Cardiac Hypertrophy, Hepatic Cirrhosis, Humerus Fracture, Dyspnoea, Urinary Tract Infection, Organ Failure, Renal Failure, Lacunar Infarction, Hypertension, Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, strength: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Dosage: 30 mg, daily
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Centyl MED Kaliumklorid; Ferro Duretter; Fragmin; Furosemide; Alprazolam; Amlodipine



Possible Lithium Citrate side effects in female

Reported by a physician from Denmark on 2012-01-03

Patient: female

Reactions: Humerus Fracture, Osteosynthesis, Rhabdomyolysis, Dyspnoea, Pyrexia, Lactic Acidosis, Fall, Organ Failure, Renal Failure, Neuroleptic Malignant Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Escitalopram
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Lithium Citrate
    Dosage: dose: 1+0+0+1.5, styrke: 6 mmol li+
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Mirtazapine
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Ziprasidone Hydrochloride
    Administration route: Oral
    Indication: Schizoaffective Disorder
    End date: 2011-10-23

Other drugs received by patient: Fragmin; Ferro Duretter; Amlodipin ^actavis^; Centyl MED Kaliumklorid; Furosemide; Alprazolam



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017